Peripheral human mAb therapy yields modulation of neuroinflammation and long-term functional recovery from lyssavirus infection.
- DOI
- 10.1080/22221751.2026.2736987
- Published
- 2026 Sep 18
- Container
- Emerging microbes & infections
- Publisher
- Not recorded
- Open access
- unknown
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1080/22221751.2026.2736987,
title = {Peripheral human mAb therapy yields modulation of neuroinflammation and long-term functional recovery from lyssavirus infection.},
author = {Huaman C and Xu Y and Lott NM and Santorella EM and Rader M and Strazzella AM and Clouse C and King JM and Melnyk M and Hong J and Yan L and Paskey AC and Luquette AE and Malagon F and Cer RZ and Bishop-Lilly KA and Perl DP and Broder CC and Xu K and Schaefer BC},
year = {2026},
journal = {Emerging microbes \& infections},
doi = {10.1080/22221751.2026.2736987},
url = {https://doi.org/10.1080/22221751.2026.2736987}
}RIS
TY - JOUR TI - Peripheral human mAb therapy yields modulation of neuroinflammation and long-term functional recovery from lyssavirus infection. AU - Huaman C AU - Xu Y AU - Lott NM AU - Santorella EM AU - Rader M AU - Strazzella AM AU - Clouse C AU - King JM AU - Melnyk M AU - Hong J AU - Yan L AU - Paskey AC AU - Luquette AE AU - Malagon F AU - Cer RZ AU - Bishop-Lilly KA AU - Perl DP AU - Broder CC AU - Xu K AU - Schaefer BC PY - 2026 JO - Emerging microbes & infections DO - 10.1080/22221751.2026.2736987 UR - https://doi.org/10.1080/22221751.2026.2736987 ER -
APA
C, H., Y, X., NM, L., EM, S., M, R., AM, S., C, C., JM, K., M, M., J, H., L, Y., AC, P., AE, L., F, M., RZ, C., KA, B., DP, P., CC, B., K, X., & BC, S. (2026). Peripheral human mAb therapy yields modulation of neuroinflammation and long-term functional recovery from lyssavirus infection.. Emerging microbes & infections. https://doi.org/10.1080/22221751.2026.2736987
Source records
- pubmed · retrieved 2026-09-25T23:24:43.304Z